Disis ML - Search Results

1

Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers.

Benz CC, Fedele V, Xu F, Ylstra B, Ginzinger D, Yu M, Moore D, Hall RK, Wolff DJ, Disis ML, Eppenberger-Castori S, Eppenberger U, Schittulli F, Tommasi S, Paradiso A, Scott GK, Albertson DG. Benz CC, et al. Among authors: disis ml. Genes Chromosomes Cancer. 2006 Nov;45(11):983-94. doi: 10.1002/gcc.20364. Genes Chromosomes Cancer. 2006. PMID: 16883574

2

Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.

Thompson JA, Dissanayake SK, Ksander BR, Knutson KL, Disis ML, Ostrand-Rosenberg S. Thompson JA, et al. Among authors: disis ml. Cancer Res. 2006 Jan 15;66(2):1147-54. doi: 10.1158/0008-5472.CAN-05-2289. Cancer Res. 2006. PMID: 16424052

3

The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens.

Lu H, Knutson KL, Gad E, Disis ML. Lu H, et al. Among authors: disis ml. Cancer Res. 2006 Oct 1;66(19):9754-61. doi: 10.1158/0008-5472.CAN-06-1083. Cancer Res. 2006. PMID: 17018635

4

Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity.

Knutson KL, Schiffman K, Cheever MA, Disis ML. Knutson KL, et al. Among authors: disis ml. Clin Cancer Res. 2002 May;8(5):1014-8. Clin Cancer Res. 2002. PMID: 12006513 Clinical Trial.

5

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.

Salazar LG, Fikes J, Southwood S, Ishioka G, Knutson KL, Gooley TA, Schiffman K, Disis ML. Salazar LG, et al. Among authors: disis ml. Clin Cancer Res. 2003 Nov 15;9(15):5559-65. Clin Cancer Res. 2003. PMID: 14654536 Clinical Trial.

6

Neu antigen-negative variants can be generated after neu-specific antibody therapy in neu transgenic mice.

Knutson KL, Almand B, Dang Y, Disis ML. Knutson KL, et al. Among authors: disis ml. Cancer Res. 2004 Feb 1;64(3):1146-51. doi: 10.1158/0008-5472.can-03-0173. Cancer Res. 2004. PMID: 14871850

7

Adoptive T cell therapy of solid cancers.

Knutson KL, Wagner W, Disis ML. Knutson KL, et al. Among authors: disis ml. Cancer Immunol Immunother. 2006 Jan;55(1):96-103. doi: 10.1007/s00262-005-0706-1. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15891880 Free PMC article. Review.

8

Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion.

Zhang H, Knutson KL, Hellstrom KE, Disis ML, Hellstrom I. Zhang H, et al. Among authors: disis ml. Mol Cancer Ther. 2006 Jan;5(1):149-55. doi: 10.1158/1535-7163.MCT-05-0206. Mol Cancer Ther. 2006. PMID: 16432173

9

CD4 regulatory T cells in human cancer pathogenesis.

Knutson KL, Disis ML, Salazar LG. Knutson KL, et al. Among authors: disis ml. Cancer Immunol Immunother. 2007 Mar;56(3):271-85. doi: 10.1007/s00262-006-0194-y. Epub 2006 Jul 4. Cancer Immunol Immunother. 2007. PMID: 16819631 Free PMC article. Review.

10

Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.

Dang Y, Knutson KL, Goodell V, dela Rosa C, Salazar LG, Higgins D, Childs J, Disis ML. Dang Y, et al. Among authors: disis ml. Clin Cancer Res. 2007 Mar 15;13(6):1883-91. doi: 10.1158/1078-0432.CCR-06-2083. Clin Cancer Res. 2007. PMID: 17363545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

302 results

Search Page